2017
DOI: 10.1055/s-0036-1590938
|View full text |Cite
|
Sign up to set email alerts
|

Asymmetric Synthetic Strategies of (R)-(–)-Baclofen: An Antispastic Drug

Abstract: Baclofen is an antispastic drug used as a muscle relaxant in the treatment of the paroxysmal pain of trigeminal neuralgia, spasticity of the spinal cord and cerebral origin. Baclofen resides biological activity exclusively in its (R)-(–)-enantiomer. In this review, various asymmetric synthetic strategies for (R)-(–)-baclofen are described.1 Introduction2 Resolution Synthetic Approaches2.1 Chemical Resolution2.2 Biocatalytic Resolution3 Asymmetric Desymmetrization3.1 Catalytic Enantioselective Desymmetriz… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
18
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(18 citation statements)
references
References 47 publications
0
18
0
Order By: Relevance
“…Baclofen (4-amino-3-(4-chlorophenyl)­butanoic acid, CAS 1134-47-0) has one chiral center, a molecular weight of 213.66 g/mol, and exists as a white, odorless crystalline powder. , The molecule contains two hydrogen bond donors, three hydrogen bond acceptors, and four rotatable bonds. Baclofen has p K a ’s of 3.89 and 9.79, with a tPSA of 63.32 Å 2 .…”
Section: Chemical Properties and Synthesismentioning
confidence: 99%
See 1 more Smart Citation
“…Baclofen (4-amino-3-(4-chlorophenyl)­butanoic acid, CAS 1134-47-0) has one chiral center, a molecular weight of 213.66 g/mol, and exists as a white, odorless crystalline powder. , The molecule contains two hydrogen bond donors, three hydrogen bond acceptors, and four rotatable bonds. Baclofen has p K a ’s of 3.89 and 9.79, with a tPSA of 63.32 Å 2 .…”
Section: Chemical Properties and Synthesismentioning
confidence: 99%
“…Baclofen abides by Lipinski’s rules and has an overall bioavailability between 70 and 85% . It is slightly soluble in water (0.712 mg/mL) and ethanol, and completely insoluble in chloroform . Baclofen ( 3 ) is sold under the trade names Lioresal (oral), Gablofen (injectable), Kemstro (disenegrating formulation), Lioresal intrathecal, and Ozobax (oral solution)…”
Section: Chemical Properties and Synthesismentioning
confidence: 99%
“…For example, (R)-enantiomers of Baclofen (antispastic agent and muscle relaxant) and Phenibut (tranquilizer and anticonvulsant) are considerably more active than the corresponding (S)-enantiomers, while anticonvulsant activity of Pregabalin (anti-epilepsy drug) is primarily related to (S)-enantiomer [23]. Consequently, considerable efforts were devoted to developing asymmetric synthesis of β-substituted GABA derivatives, including chemical and biocatalytic resolution, asymmetric reduction, desymmetrization, aldol addition, and nucleophilic substitution [24][25][26]. For the past decade, the asymmetric Michael addition of carbon nucleophile to α,β-unsaturated compoundbearing nitro or carbonyl groups gained impressive progress, providing straightforward access to γ-nitrocarbonyl compounds as key chiral intermediates that can be converted Significantly, biological activity of β-substituted GABA derivatives depends on their absolute configuration.…”
Section: Introductionmentioning
confidence: 99%
“…The asymmetric synthesis of chiral compounds is, therefore, an essential field in organic chemistry. In particular, chiral β-aryl propanamines are extremely interesting candidates as precursors of pharmaceuticals and active molecules: for example, Lorcaserin, an anorectic drug that has been typically synthesized by chiral resolution; OTS514, a marketed inhibitor of a serine-threonine kinase that is often overexpressed and transactivated in several types of cancer; and LY-392098, a potent positive allosteric modulator of 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)-propanoic acid (AMPA) receptor . Moreover, we can envision the synthesis of several drug intermediates such as 3-methylindolines in few steps from β-aryl propanamines (Figure ).…”
mentioning
confidence: 99%